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Summary 
To study the development of B lymphocyte memory, we identified and isolated splenic B cells 
expressing a highly defined antibody variable region that constitutes a reproducible and pre- 
dominant component of the memory antibody response to p-azophenylarsonate (Ars). Isolation 
was achieved during the primary immune response by surface staining and flow cytometry using 
a specific anti-idiotypic antibody called E4, which recognizes this canonical V region, encoded 
by one set ofV gene segments. The isolated E4  + cells displayed all of the phenotypic character- 
istics of germinal center centrocytes, including a low level of surface Ig, a lack of surface IgD, a 
high level of receptor for peanut agglutinin, and expression of mutated antibody V genes. 
E4 § B cells were first detected in the spleen 7-8 d after primary immunization, reached peak 
numbers from days 10-13, and waned by day 16.  Surprisingly, at their peak, E4  + cells com- 
prised only 40,000 of all splenocytes, and half of these failed to bind Ars.  Using this number, 
we estimate the total number of M-specific memory-lineage cells in the spleen to be no more 
than 50,000 (0.1%) at any one time, and presumably far fewer that are committed to the mem- 
ory pool Chromosomal copies of rearranged V genes from single E4 + cells were amplified by 
nested PCR, and the amplified products were sequenced directly without cloning, using stan- 
dardized conditions that disclose virtually no Taq polymerase errors. V gene sequence analyses 
of E4 + ceils isolated from single mice confirmed their canonical nature and revealed that they 
were derived from few precursors. In the average mouse, the E4 + pool was derived from fewer 
than five canonical precursors. Somatic mutations were found within the V genes of almost all 
cell isolates.  At day 13, a significant fraction of E4 + cells had mutations known to increase anti- 
body affinity for Ars, suggesting mey were products of at least one cycle of post-mutational an- 
tigen-driven selection. However, the lack of  shared mutations by clonally related cells indicated 
that the selective expansion of mutant subclones typical of memory responses had not yet taken 
place. This was supported by the observation that half of the E4 + cells failed to bind Ars. Col- 
lectively, our results indicate that the memory compartment is a highly selected entity, even at 
relatively early stages of the primary immune response when somatic mutation and clonal selec- 
tion are still in progress. If germinal centers are the source of memory B cells, our data suggest 
that B cell memory may be derived from only a small fraction of all germinal centers. 
T 
he development of memory B  cells is strongly influ- 
enced by two antigen-dependent processes. One of  these 
is a poorly defined somatic hypermutation mechanism that 
targets rearranged antibody variable region genes expressed 
by immune participants  (1-12).  The second is  an intense 
selection process that recruits into  the  memory compart- 
ment rare B  cell mutants  expressing antibodies  with im- 
proved affinity for antigen (reviewed in reference 13). To- 
gether,  these  processes  appear  to  be  necessary  for  the 
maturation of antibody affinity, which is observed in mem- 
ory  or  T  cell-dependent  antibody  responses.  However, 
neither somatic mutagenesis nor the dynamics of cell selec- 
tion leading to recruitment into the memory B  cell com- 
partment are understood in any significant detail, 
Recent molecular studies  have  provided concrete evi- 
dence that the anatomic site of somatic hyperrnutation and 
affinity-based selection is the germinal center (GC) 1 (14-20). 
GC B cells have been isolated by microdissection of frozen 
~Abb~eviations used in this paper: Am, p-azophenylarsonate;  GC, germinal 
center; PNA, peanut agglutinin. 
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gen and peanut agglutinin.  In these studies, hapten-specific 
GC B  cells were found  to comprise ~1-2%  of all spleno- 
cytes during the second week after immunization  (18,  21). 
PCR-based  sequencing  studies  of their expressed V  genes 
indicated  that  they  contained  somatic  mutations,  some- 
times  including  specific  mutations  associated  with  affinity 
improvements  (17,  18).  In contrast,  few or no  observable 
mutations  have  been  seen  in  V  genes  of B  cells  isolated 
from  other  anatomic  sites  in  secondary  lymphoid  tissues 
(14,  18). 
The  fraction  of GC  cells that will  ultimately  end  up  in 
the  memory  t3  cell  compartment,  however,  is  unknown 
and has been difficult to assess using model anti-hapten im- 
mune  responses  in  which  the  primary  response  is  domi- 
nated by clonotypes that constitute only a minor fraction of 
the  memory  response.  For  example,  in  both  the  anti- 
oxazotone and anti-NP immune responses, 13 cells express- 
ing  particular  VH/VL  pairs  dominate  early,  but  wane  in 
frequency as the response progresses (7, 22). In the primary 
immune response  to NP,  V  gene  sequences  derived  from 
germinal  center  B  cells  revealed  that  only  one  of several 
germinal  centers  examined  contained  B  cells with  a  diag- 
nostic  affinity-improving  somatic  mutation  (14--16).  This 
suggests  that  B  cells  from  most  germinal  centers  are  not 
destined  to enter the memory compartment in which mu- 
tant cells expressing high-affinity antibodies  typically accu- 
mulate.  In  addition,  phylogenetic  analyses  of hybridoma 
cells have indicated that progeny of relatively few precursor 
B  cells dominate any given memory immune response (10- 
12,  23,  24).  These  observations suggest that relatively few 
of the  developing clones  in the primary immune response 
contribute to the pool of memory B  cells. 
To study the development of presumably rare memory- 
lineage t3 cells, we exploited the antibody response of A/J 
mice to p-azophenylarsonate  (Ars), which has been exten- 
sively characterized (25, 26). Hybridoma sampling studies have 
revealed  that  ~50%  of anti-Ars  memory B  cells  express  a 
dominant idiotype (IdCR), and the majority of these ("~80%) 
express  a  defined  "canonical"  combination  of V  gene  seg- 
ments (VHIdCR, Da16.1, JH2; and VKIdCR, J~l)  (5, 8, 27- 
29), with two specific junctional residues that are necessary 
for Ars binding:  serine at position 99 in the Vr~-D~16.1 junc- 
tion (30); and arginine at position 96 in the VK-JK1 junction 
(31)  (see  Fig.  1).  Two  variable junctional  residues  (at  the 
V,-D and the D-JH joins  ) are the only sources of variability in 
unmutated  canonical  V  regions  (Fig.  1).  Results  of hybri- 
doma sampling studies have shown that canonical Ars-spe- 
cific B  cells are only a minority of all Ars-specific cells partic- 
ipating in the primary immune response, but they emerge to 
dormnate the secondary or memory immune response, when 
they  comprise  "40%  of all  Ars-specific  cells  (8).  Their 
emergence  appears  to  be  the  consequence  of an  affinity- 
driven  selection  process.  Most  canonical  hybridomas  iso- 
lated late in the primary immune response or in the memory 
response  carry V  gene somatic mutations that confer affin- 
ity improvements upon the antibody product.  In addition, 
many  of them  carry  specific  recurrent  somatic  mutations 
that are known  to enhance  affinity for Ars  (32).  These in- 
clude  threonine  to  isoleucine  and  lysine  to  threonine 
changes at positions  58 and 59,  respectively, in VH  CDR2 
(33).  As such,  the mutated  canonical  V  region  is the most 
reproducible component of the memory immune response. 
A second advantage in studying memory development to 
Ars is the  availability of a  monoclonal  anti-idiotype  called 
E4,  which  recognizes  canonical  V  regions  almost  exclu- 
sively  in  a  hapten-inhibitable  manner  (34,  35).  In  this 
study, we used E4 to identify and isolate cells belonging to 
the memory lineage during the primary immune response. 
V,  and VK genomic  templates were  amplified from single 
isolated cells and directly sequenced to preclude artifacts as- 
sociated  with  PCR  amplification  of multiple  homologous 
templates and with cloning of PCR. products (36). The re- 
sults indicate  that,  already at 13 d  after a primary immuni- 
zation,  the potential pool of memory cells is small, hetero- 
geneous with respect to antigen binding,  and derived from 
very few precursors despite ongoing selection. 
Materials and Methods 
Immunization,  Splenocyte Staining, Flow Cytometry and Cell Sort- 
ing.  Specific pathogen-free A/J mice  (8-12  wk old)  were im- 
munized i.p. with Ars-KLH or KLH (100  Ixg) emulsified in in- 
complete Freund's Adjuvant.  6-24 d later,  erythrocyte-depleted 
splenocytes were  stained with  biotinylated E4  (10  Ixg/ml),  fol- 
lowed  by Streptavidin-PE  (0.1 Ixg/ml; Becton  Dickinson,  San 
Jose, CA).  Splenocytes were also stained with  FITC-anti-Macl 
(M1/70,  5  Ixg/ml)  and  FITC-anti-IgD  (JA12.5,  3  Ixg/ml)  to 
identify and exclude macrophages, antigenically naive B cells, and 
cells with a propensity to stain nonspecifically. In some experi- 
ments,  FITC-conjugated  to peanut agglutinin  (PNA,  1 I~g/rrd; 
Sigma)  or anti-B220  (RA3-6B2,  10 Ixg/rnl)  was used to identify 
germinal center B cells. Conjugation of antibodies with biotin or 
FITC  was based  on  described  methods  (37).  During  and  after 
staining,  cells were kept in an ice-chilled and sterile-filtered buffer 
(Staining Buffer) of calcium-free Dulbecco's PBS (GIBCO BRL, 
Gaithersburg, MD) supplemented with heat-inactivated FCS (2%; 
HyClone, Logan, UT) and sodium azide (0.1%) before cell sort- 
ing to minimize surface receptor capping and internalization.  To 
demonstrate  the receptor-specific nature  of E4 staining,  control 
samples of splenocytes were pretreated with a competitive inhibi- 
tor consisting of Ars conjugated to BSA (ArsBSA: 200 txg/m]) for 
15 rain before E4 staining. 
Stained splenocytes were analyzed first for size (forward scatter) 
and granularity (side scatter),  then for color (PE and FITC) using 
a flow cytometer (EP/CS  751;  Coulter,  Hialeah,  FL)  eqmpped 
with an argon-ion laser (h =  488 nm), a neutral density filter, and 
Cicero  Data  Acquisition  software  (Cytomation,  Fort  Collins, 
CO).  In general,  15,000 events in the two-color g-ate were ana- 
lyzed for each sample.  In some  experiments,  cells  were  sorted 
into  an  Eppendorf  tube  containing  Dulbecco's  PBS  supple- 
mented with FCS (15%) and ArsBSA  (200  ~g/ml) to inhibit cell 
aggregation and to prolong B cell survival in vitro. Cells were an- 
alyzed at a rate of~~  events/s and sorted at a rate of~l,500 
events/s, yielding about 3,500  collected cells in 2 h with an ap- 
proximate collection efficiency of 50%. 
Determining Cell Size.  The  diameters  of larger  and  smaller 
splenocytes, and B-hybridoma cells were determined by photo- 
graphing cell  samples mixed with  Latex Microspberes  (Coulter 
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with a phase contrast microscope (Nikon Diaphot - TMD). The 
diameter of ~20 cells from each sample was measured. 
Single Cell V Gene Amplification and Sequence  Analysis.  Sorted cells 
were gendy concentrated at 4~  in a microfuge (4,000 rpm ￿  10 
rain).  Cells were then visualized by phase contrast microscopy in 
isolated microdrops to confirm their singularity,  as described (38). 
Microdrops containing single cells were aspirated using a P20 Pi- 
petteman (Rainin, Wobum, MA) and subjected to direct V H and 
VK  gene  amplification  using  canonical  genomic  VHIdCI~  and 
VKIdCR-specific ohgonucleotide primers in a nested polymerase 
chain reaction (PCR), as described (38). Microdrops lacking cells 
were also picked in each experiment to serve as negative controls. 
Special precautions were taken throughout these  experiments to 
minimize and assess for any chance of DNA contamination be- 
fore PCR amplification.  Amplification products were visualized 
by  electrophoresis  of 1-pJ  samples  through  2%  agarose  gels. 
PCR-amplified V H and VK gene products from single cells were 
purified  and sequenced with 32p-labeled  primers  using Version 
2.0 of the Sequenase  Sequencing Kit (United States Biochemical, 
Cleveland,  OH),  with  modifications of the manufacturer's rec- 
ommendations as described (38). PCIk and sequencing ohgonu- 
cleotide primers  used for these experiments were described (38). 
Statistical Analyses.  Mean values and standard  errors were cal- 
culated with the JMP statistical software program, version 2.0.5 
(SAS Institute,  Cary, NC). 
The  total  number of precursor clones  present  in the spleen, 
from which the sample  population of B cells was obtained, was 
estimated  using the mathematical model to the "hidden species" 
problem, originally  developed by KA Fisher in 1943, and applied 
to the study of B cell precursor numbers by Blier and Bothwell 
(23). Briefly, the equation for the model is k  =  N/S ￿  (1 - e-X), 
where the experimental sample  consists of N  total cells of S dis- 
tinct clones,  and k is related  to the total number of clones in the 
sample  population  (St) by the equation S  t  =  N/k.  An iterative 
method was used to estimate k, and a X  2 goodness of  fit statistic to 
estimate  95%  confidence intervals  for St.  Calculations  assumed 
that each clone was represented in equal numbers, and thus sam- 
pling followed a Poisson distribution. 
Results 
Flow Cytometric Analysis  of Memory-lineage B  Cells during 
the Primary Anti-Ars Response.  To identify and isolate po- 
tential  memory-lineage B  cells  during  their  development, 
we  exploited  a  monoclonal anti-idiotype  (E4)  that recog- 
nizes the canonical V region product of the dominant mem- 
ory population of Ars-specific B  cells  (Fig.  1).  Using flow 
cytometry,  E4 §  cells  were  analyzed  in  Ars-immunized 
mouse samples obtained 6, 8, 10, 13, 16, 20, and 24 d after 
immunization.  Splenocytes were initially gated on the basis 
of size  and  granularity  in  order  to  separately  analyze  the 
larger,  activated  lymphocytes  (Region  1  or R1)  and  the 
smaller,  presumably  resting  lymphocytes  (tk2),  while  ex- 
chiding  macrophages  and  R_BC's  (Fig.  2  a).  1<1  and  1<2 
cells were then analyzed to identify E4 §  (PE)-stained  cells 
that were Mac1- and slgD-  (1<5). The 1<1 gate was deter- 
mined  empirically.  Increasing  the  size  of this  gate  to  in- 
clude additional larger cells only decreased the frequency of 
E4 +  cells.  Similarly,  the R5  gate was  adjusted  empirically 
using the pattern  of stained splenocytes from mice immu- 
VHklCR  (99)  ji12 
'  Arg 
V KIdCR  (96)  JK  1 
Figure 1.  The "canonical" configuration  ofV gene segments and junc- 
tions that encodes the dominant V region of the memory antibody re- 
sponse of A strain mice to p-azophenylarsonate. X and Y represent the 
only codons that vary among unmutated versions. 
nized only with KLH as a control. A total of 66 mice were 
studied in this manner, primarily at 10 or 13 d after immu- 
nization. 
A  very  small  but  reproducible  subpopulation  of E4  +, 
Macl-  and IgD- (R5) cells emerged 7 to 8 d after primary 
Ars immunization  among the larger  10-15% of total sple- 
nocytes (I<1- Fig. 3 a). Their numbers peaked from days 10 
(0.28 +-- 0.05% SEM) to 13 (0.30 +_- 0.06% SEM), and waned 
substantially by day 16. These cells averaged 10 __-  1 p,m in 
diameter.  The antigen specificity of E4 + cells was assessed 
by competitive inhibition  of E4-staining with an excess of 
ArsBSA. This reduced the percentage of E4 + cells by ~"50% 
in day  10  and day  13  samples,  indicating that  one-half of 
the E4 + cells had apparently lost the  capacity to bind Ars, 
perhaps due to the recent acquisition of somatic mutations. 
Inhibition of E4 staining with ArsBSA was also assessed for 
KLH-immunized  mice  and  was  found  to  be  negligible 
(data not shown). The smaller 50% of the splenocytes (R2), 
averaging 6  •  1 p~m in diameter,  were similarly analyzed. 
E4 +  cells were "~0.05%  of the  small  splenocytes obtained 
10 and 13 d after Ars immunization (Fig. 3 b). This is about 
six'fold  less  than  the  percentage  of E4 +  cells  observed 
among larger splenocytes,  indicating  their  relative  enrich- 
ment among larger cells. 
E4  + B Cells Are PNAhl and B220  +.  To further  charac- 
terize E4 + B  cell isolates,  sorted cell samples were stained 
with PNA or anti-B220 to identify germinal center B  cells 
(39-44). Sorted E4 + cells or unsorted splenocytes that were 
stained  with  FITC-PNA or FITC-anti-B220 were reana- 
lyzed by flow cytometry (Fig.  2  b).  Only 5% of total sple- 
nocytes stained brightly with PNA, while 78% of the large 
E4 +  cells  and  65%  of the  small  E4  +  cells  were  PNAhi. 
Given  this  enrichment  of PNAhi  cells  among sorted  E4 § 
cells,  the low representation  orE4 + cells among total large 
(~0.3%)  and  small  (~0.05%)  splenocytes,  and  intrinsic 
sorting limitations,  we infer that the large majority of iso- 
lated E4 + cells were PNAhi. 
A  similar  B220  re-analysis  of sorted  E4 +  cells  revealed 
that 80%  of the large E4 +  cells and 61% of the small E4 + 
cells  were  B220 +  (Fig.  2  b).  Since  most  splenocytes  are 
B220 +  (e.g.,  60%  of total splenocytes stained with B220), 
this  finding  does  not  indicate  a  significant  enrichment  of 
B220 +  cells  in  the  sorted  populations.  However,  it  con- 
finns that the majority of sorted cells were B220 + B  cells, 
and correlates well with the percentage of sorted cells that 
were PNAhi. 
Isolated E4 + Cells Carry Rearranged Canonical V~I, VK, Jf~, 
and JK genes.  To  confirm that the  cells identified by flow 
2055  Liu et al. Figure 2.  Flow cytometric analysis of E4 + splenocytes during the primary antibody response to Ars. (A) A representative flow cytometric analysis of 
splenocytes obtained from A/J mice 13 d after primary immunization  with ArsKLH. Splenocytes were first assessed by size (forward scatter) and granular- 
ity (side scatter) to identify larger (R1,  13.8% of total splenocytes) and smaller (R2, 49.2%) cells for separate two-color analyses. Of particular interest in 
the two-color gates are the E4 + (PE), Mac1 - and slgD- (FITC) cells of region 5 (R5). In this example, tk5 cells comprise 0.5% of the larger splenocytes 
of R1, and 0.04% of the smaller splenocytes of R2. To determine the background for E4 staining, a cell sample from a carrier (KLH)-only immunized 
mouse was simultaneously analyzed; the R5 percentage for this sample is shown as R5(KLH). E4 + cell frequencies adjusted for background were reported 
as tk5 - R5(KLH).  (/3) PNA and B220 staining of  E4 + splenocytes. Sorted large E4 +, Mac1 and IgD-negative splenocytes were stained with FITC-PNA 
or FITC-anti-B220 and reanalyzed by flow cytometry. In each diagram, the stained sorted sample (filled graph) is compared with a simultaneously stained, 
but unsorted sample (solid line) from the same mouse. Results pertaining to the bracketed regions of positively stained cells are tabulated below each flow 
cytometric diagram. 
cytometry carried canonical V  gene segments characteristic 
ofanti-Ars memory B  cells, we isolated E4 + cells from four 
mice  immunized  with  Ars-KLH.  Larger  cells  were  ob- 
tained from  2  mice  at  day  13,  and one mouse  at  day  10; 
smaller and larger cells were also obtained from one mouse 
at day  13.  Single E4 §  cells were visualized microscopically 
and  manually aspirated  into  tubes  using strict  conditions 
and controls to prevent and assess for contamination. Chro- 
mosomal  Vrt  and  V~  genes  from  single  E4 §  cell  isolates 
were  individually amplified ("o1014-fold)  in a  nested PCR 
protocol specific for rearranged canonical V  genes (38). A1- 
iquots of PCR  reactions were analyzed by agarose gel elec- 
trophoresis. 
From  these  four mice,  a  high  frequency of E4 +  B  cells 
carried rearranged VHIdCt( and/or VKIdCR genes. 53/175 
(30%)  single  cells  yielded  one  or  both  canonical  PCR 
products: 48 VHIdCR,  34 VKIdCR, 28 both VHIdCR and 
VKIdCt(  (Table  1).  Furthermore,  the  amphfied  VnIdCtk 
and  V~r  products  were  "-~650  and  780  bp  long,  re- 
spectively,  which is  consistent with rearrangements to  ca- 
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Figure 3.  Emergence of E4  + 
splenocytes during the  primary 
antibody response to  Ars. (A) 
Timecourse  demonstrating the 
peak emergence and duration of 
the  subpopulation of large E4  + 
IK5 cells (10 -  1 t~m in diame- 
ter).  The  percentages of these 
cells in the spleen were adjusted 
for background E4 staining and 
reported  as  I~5-R5(KLH)  (see 
Fig.  2  A).  Mean values are 
shown  (solid line). To  quantify 
the Ars-specific fraction of E4  + 
cells,  similar calculations were 
derived  for  samples pretreated 
with AtsBSA to block E4 stain- 
ing. Mean values for these sam- 
ples  adjusted for  background 
[RS(K~sBSA)  -  R56~BSA/ 
KLH)]  are  also  represented 
(dashed line).  SEMs for  day  10 
and day 13 are shown. (B) Time- 
course for  small E4  +  R5  cells 
(6 +  1 I~m in diameter), using 
calculations  and terminology  de- 
scribed above. 
nonicalJ.2 andJK  1 gene segments. Only one PCR product 
was smaller than expected, consistent with a non-canonical 
VKIdC1K-JK2 rearrangement (Table 1).  No PC1K products 
were  obtained  from  37  negative  control  microdrops  in 
these experiments. It is not surprising that some of the cell 
isolates yielded no PC1K products, given limitations on the 
efficiency of sorting such a small fraction of spleen cells. 
Table  1.  Rearranged Canonical  V  Genes in Single E4 + B  Cells 
Mouse* 
Single cells yielding: 
Single cell VH or VK  VH  VK  Both VH  No cell 
isolates  product  product product  and VK  controls* 
1-day 10  28  12  11  10~  8  8 
2-day 13  30  10  8  9  7  10 
3-day 13  70  16  15  6  5  10 
4-day 13  47  15  14  9  8  9 
Total  175  53  48  34  28  37 
*PC1K results from single E4 + cells obtained from four mice on the in- 
dicated days following immunization. Cells that  utilized rearranged 
VHIdCIK and VKIdCIK  genes gave single amplified bands 647 and 782 
base pairs long, which are consistent with canonical VHIdC1K-JH2 and 
VKIdCIK-JK1 rearrangements,  respectively. 
*Numbers in this column indicate control microdrops without  cells 
that were subjected to the same PC1K tests. None of them yielded PC1K 
products. 
~One of these 10 products was a smaller size, consistent with a nonca- 
nonical VKIdCR-JK2 arrangement. 
Few Splenic Memory  Progenitors  Two  Weeks Post-immuniza- 
tion.  We  can  estimate  the  size  of  the  hapten-specific 
memory cell compartment in the spleen based on flow cy- 
tometric analyses of E4-specific cells. At day 13, the size of 
the large E4 § cell compartment was '~0.30% ￿  10% (larger 
splenocytes)  ￿  (5  ￿  107) cells/spleen  =  '--q5,000  large 
E4 + B  cells/spleen. A  similar calculation reveals an equiva- 
lent estimate for the  number of small E4  +  B  cells/spleen 
(N0.05%  ￿  50%  ￿  [5  ￿  107]  =  "~15,000).  Considering 
that our flow cytometric analyses excluded ",~25% of all B 
cells,  we  adjusted  the  estimate  to  ~40,000  total  E4  +  B 
cells/spleen. Finally, since E4 identifies "-'40% of the mem- 
ory  response  to  Ars,  as  observed in serologic  and hybri- 
doma  sampling studies  (8,  26),  the  size  of the  complete 
Ars-specific  memory  cell  compartment  presumably  does 
not exceed 100,000 cells/spleen. This is an upper-end esti- 
mate for actual memory cells because only half of the E4 + 
cells  bound  Ars,  and  an  unknown fraction  presumably 
bound Ars with reduced affinity due to somatic mutagene- 
sis.  Such  cells  are  almost  certainly destined for  exclusion 
from  the  memory  pool,  based  on  hybridoma  sampling 
studies (8, 26). 
Since  our  sorting  procedure  excluded  any  cell  that 
stained  specifically  with  anti-IgD  or  anti-Mac1  or  that 
might have stained nonspecifically (e.g.,  via Fc receptors), 
we were  concerned that the low frequencies of canonical 
cells observed might be misleading. For example, our E4  + 
Ars  + B  cell frequencies were at least  10-fold less  than the 
hapten-specific frequencies described by McHeyzer-Will- 
iams et al. (18) in the anti-NP response. To test our numeri- 
cal conclusions, we estimated the number of cells in unffac- 
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expressing the canonical set ofV gene segments. Total spleen 
cell suspensions  were prepared  13  d  following immuniza- 
tion with either Ars-KLH or KLH. PCR amplifications for 
rearranged  canonical  VHIdCR  genes  were  performed  on 
lysates derived from groups of 100 or 150 splenocytes (Ta- 
ble 2).  From the ArsKLH and the  KLH-immunized con- 
trol  mice,  we  found  that  ~1/1,000  and  ~1/850  cells 
yielded  a  VH  PCR  product  of the  appropriate  size  for  a 
VHIdCR-JH2 rearrangement,  respectively.  This is  in good 
agreement  with  random  hybridoma  sampling  studies  of 
Manser et al.  (45)  who found that ~1/350  LPS-generated 
hybridomas expressed the VHIdCR gene with any JH gene 
segment.  To  further  assess  whether  these  VH  gene  PCtK 
products were indeed canonical,  we sequenced five prod- 
ucts each from ArsKLH and KLH-only immunized mice. 
All  10  products  encoded  a J.2  gene  segment;  however, 
only 5  of 10  used  the  canonical VnldCR  gene  segment, 
while  the  other five encoded identical  VH  gene  segments 
similar to VHIdCR. Furthermore,  0 of 10 used the canoni- 
cal Df116.1 gene segment, reinforcing our view that canoni- 
cal B  cells  do not dominate  the immune response because 
of precursor frequency considerations, and that the cells we 
are  examining  represent  a  highly  selected  subset  that  are 
preferentially expanded as the response progresses. 
E4 + B  Cells  Carry  a  Rearranged  Canonical  D  Gene  Seg- 
ment, Have Critical Junctional Residues and Somatically Mutated 
V  Genes.  PCR-amplified V  gene products  of single E4 + 
cells were directly sequenced using a method that was pre- 
viously  standardized  with  hybridomas  (38).  For  the  four 
mice described above,  78  of 82 PCR  products  (95%)  ob- 
tained from 53 E4 + cells were entirely canonical (Table 3). 
Two exceptions (sample no. 3-26H and no. 4-$27H) con- 
tained  a  D  gene  segment  other  than  the  canonical Dn16.1 
(Fig. 5); a third PCR product did not contain the canonical 
arginine  codon at  the  VK-JK junction  (sample  no.  2-22K 
has a VK junctional TGG codon encoding a tryptophan resi- 
due); a fourth product described in Table 1 was smaller than 
expected and consistent with a non-canonical VKIdCR-JK2 
rearrangement.  These  data demonstrate  that the large ma- 
jority of the isolated E4 § cells producing at least one VH or 
V~  amplification product were using entirely  canonical V 
gene segments and junctions. We interpret this result to in- 
dicate that most of the E4 + cells  visualized by flow cytom- 
etry  were  also  expressing  the  canonical  V  region  of the 
anti-Ars memory response. 
By day 13, 37 of 41 E4 §  cells  (90%)  had acquired point 
substitution mutations in their rearranged canonical V genes, 
while  10 of 12 (83%)  cells  isolated on day 10 had acquired 
mutations.  The  mutation  frequency  calculated  from  data 
on all  cells  was  255/30917  =  0.82%.  This  was  "~ 
higher than the previously determined error frequency of our 
V  gene  amplification  and  sequencing  method  (1/7590  or 
0.01%)  (38), supporting the interpretation that the vast ma- 
jority of observed mutations were not artifacts of amplifica- 
tion.  The  mutation  frequency  at  day  13  for  VH  and  VK 
genes was 212 mutations/22705  sequenced bases or 0.93%. 
The day 10 mutation frequency of 43/8212  or 0.52%  was 
slightly lower than that of day 13. 
The pattern and idiosyncrasies of the observed mutations 
was consistent with the interpretation that they are products 
of the physiologic V  gene mutation mechanism. 57% of the 
mutations were transition  substitutions,  especially G  to A, 
while  43%  were  transversions  (random  substitution  muta- 
tions  would  favor transversions  to  transitions  2:1).  These 
biases,  which  are  typical of hybridoma V  gene  mutations 
(46,  47),  were  maintained  when  only non-coding  muta- 
tions (i.e.,  silent and flanking regions),  that are presumably 
free of selection pressures,  were  examined.  High frequen- 
cies of somatic mutations were observed at positions 31 and 
105  in  canonical heavy chain  genes,  as  is  also  true  of V, 
genes expressed by sampled hybridomas (data  not shown). 
Position 31 appears to be an intrinsic "hotspot" for the mu- 
tation mechanism as described by Betz et al.  (47),  and re- 
cent work from our laboratory has identified position  105 
as intrinsically highly mutable,  based on an analysis of nu- 
Table 2.  Frequency of Canonical Heavy Chain Rearrangements in Unsorted Splenocytes 
Ars 1"  Ars2*  Ars3**  KLHI~  KLH2~  KLH3*~ 
Number of groups testedH  16  16  48  16  16  36 
Number of groups with an 
appropriate  size PCR fragrnent￿82  2  1  7  3  1  6 
Number of PCR products/ 
number of splenocytes  2/1600  1/1600  7/7200  3/1600  1/1600  6/5400 
Number of canonical VHDJ. genes/ 
number of PCR products sequenced  0/5  0/5 
*  Splenocytes prepared from three A/J mice immunized with Ars-KLH 13 d earlier. 
*For these two mice, each tested group contained 150 unsorted splenocytes. Five PCR products from each mouse were sequenced to determine the 
frequency of canonical gene segment usage. 
~Splenocytes prepared from three A/J mice immunized with KLH-only 13 d earlier. 
IIEach group containing 100 unsorted splenocytes were subjected to PCR amplification to detect B cells using rearranged VHIdCR-JH2  genes. 
￿82  VHIdCR-JH2 rearrangement produces a single amplified fragment of "~650 base pairs. 
2058  Development of  B Cell Memory Table  3.  Canonical  V Gene Segment and  Junction Usage by Single  E4  §  B  Cells 
Mouse*  VrtldCR-  Pos.  99 serine  Dtt16.1  JH2  VKIdCR  Pos.  96 arginine  JK 1 
1-day10  11/11r  11/11  11/11  11/11  9/9~  9/9  9/9 
2-day 13  8/8  8/8  8/8  8/8  9/9  8/9  9/9 
3-day13  15/15  15/15  14/15  15/15  6/6  6/6  6/6 
4-day13  14/14  14/14  13/14  14/14  9/9  9/9  9/9 
Total  48/48  48/48  46/48  48/48  33/33  32/33  33/33 
*Sequence  analysis of E4 + B  cells from four mice  (described in Fig. 2  and Table  1) revealed that V  gene segment and junction usage in 78 of 81  V 
gene products derived from 53 cells was restricted to the specific canonical combination illustrated in Fig.  1. 
* Numerator indicates number of canonical PCR products. Denominator indicates total number of PCR products. 
One cell that yielded a smaller than expected V~ PCR product,  consistent with a non-canonical VxldCP,-JK2 rearrangement (see Table 1), was not 
sequenced and was excluded from this table. 
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B  CDR2  :  large  cells 
r 
55  58  59  66 
N  G  Y  T  K  Y  N  E  K  F  K  G 
VHIdCR  AAT GGT TAT ACT AAG TAC AAT GAG AAG TTC AAG GGC 
4-L5H  .........  ~  ,  .T ..................... 
4  -L9H  .................................... 
4-L20H.  ,A ......  [~  ........................ 
4-L21H  .....  ~  T  ..................... 
CDR2 :  small  cells 
55  58  59  66 
N  G  Y  T  K  Y  N  E  K  F  K  G 
~HIdCR  AAT GGT TAT ACT AAG TAC AAT GAG AAG TTC AAG GGC 
4-SiH  ....  A ............................... 
4-S6H  .......  G .................  G .......... 
4-$8H  ....  T ...................  G..  C ........ 
4-S9~  ..........  O ......................... 
4-Sllh  ..............  C  ....  ~...A  ..........  A. 
4-$20H T .....  C ...................  T  ......... 
4-$22H C...C  .........  C  ........  C  .  .A ......... 
4-$27H  .................................... 
4-$30H C.. AA. C..  T~  ........................ 
4-$34H  ..............  A  ...........  C  ......... 
Figure  4.  VH  CDP,.2  mutations  in  E4 +  B  cells.  (A)  Nucleotide  se- 
quences ofV H CDI:(2  regions  of large E4 + B  cells obtained  10 or  13  d 
post-innnunization.  Dots  indicate identity with the reference  germline- 
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merous  hybridoma  V  gene  sequences  (unpublished data). 
Thus, the V  gene mutations observed in our sampled cells 
had the signature features  of the hypermutation mechanism 
previously defined in hybridoma sequencing studies. 
An affinity-based selection process had apparently oper- 
ated  on  mutant precursors  of the  isolated  cells.  10  of 27 
(37%)  large  cells  isolated  on day  13  had  acquired  one  or 
two  specific  V.  CDR2  replacement  mutations known to 
improve  Ars-binding affinity three-  to  eightfold  (Vrt pos. 
58: Thr to Ile; pos. 59: Lys to Thr) (32) (Fig.  4 a and b). At 
day  10,  only one  in  11  cells  or  9%  had acquired  one  of 
these specific affinity-improving mutations (Fig. 4 a). Inter- 
estingly, only 1 of 10 small  cells that were  isolated on day 
13  had  acquired  one  of these  mutations  (Fig.  4  b),  Al- 
though selection  had  evidently operated  on precursors  of 
large cells  expressing mutant antibody products by day 13, 
there were few ~h,,red silent mutations or noncoding muta- 
tions  (located  3'  of V  exons)  among  cells  derived  from 
common precursors (see  below). Hence, sequential rounds 
of selection,  characteristic  of advanced  stages  of memory 
development, apparently had not yet occurred. 
Memory-lineage Cells Den'vedjgom Few [4vmrsors.  Smnpled E4  + 
cells  were  assigned to lineages by inspection of junctional 
codons at positions 100 and 107 (X and Y in Fig.  1) and the 
third base of the serine 99  codon in canonical H  chain V 
genes.  Sequenced  VH  gene  products  from  E4 +  cells  ob- 
tained 10 and 13 d after immunization revealed that these 
junctions  were  limited  in  diversity,  suggesting  common 
encoded  sequence  (5).  Mutations  resulting  in  amino  acid  changes  (re- 
placement mutations) are in bold. The boxed nucleotides produce amino 
acid changes  (position  58  ACT  to  ATT,  Thr  to  Ile;  and position  59 
AAG to ACG, Lys to Thr) that are known to increase binding affinity for 
Ars (32).  Sample designations are consistent with other figures  and tables 
(e.g.,  1-4H: mouse  no.  1,  sample  no.  4,  H  chain).  (B)  Nucleotide  se- 
quences of VH CDR2  regions from small and large  E4 + B  cells  obtained 
from the same mouse,  13  d  post-immunization.  Parameters  used to  de- 
scribe  these samples and their sequences  are the same as in the previous 
figure. All large and small cells from this mouse were apparently derived 
from the same germline precursor,  based on junctional  sequences  in VH 
CDR3  (see Fig. 5). precursor origins.  In Fig.  5,  sequences  most hkely derived 
from  common precursor  cells  are  grouped together.  Two 
samples  that  did not contain  the  canonical  Dn16.1 segment 
were not included in this analysis.  Sampled cells from mice 
no.  1 through no. 4 in Fig. 5 were apparently derived from 
2, 5, 4, and 1 clonal precursor(s),  respectively.  Based on the 
frequency  of repeat  sequences,  we  used  a  mathematical 
model ("hidden species")  to obtain an estimate  of the total 
number  of canonical  precursors  from  which  the  sampled 
memory-hneage  cells were  derived  (23).  With  95%  confi- 
dence, we estimate the number of canonical precursors was 
2, 8  (range 5 to  11)  , 7  (range 6  to 9), and 1 precursor(s) in 
the four mice,  respectively.  This  indicates  that,  as early  as 
day  13,  memory-lineage  cells  are  derived  from  a  limited 
number of precursors  that had undergone  extensive  clonal 
expansion.  Taking  11  as  the  upper  estimate  for  canonical 
precursors  (from mouse  no.  2),  and  assuming that  40%  of 
4----VHIdCR--  ser X 
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1-1914 
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["  2-10H 
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3-5214 
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3-40H 
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4-L9H 
4-L20H 
4-L21H 
4-SIH 
4-S6H 
4  -SSH 
4-$9H 
4-SLIM 
4-$20H 
4-S22H 
4  $30H 
4-$34H 
4 -$27H 
Dfll 6.1  Y  JH  2 
98  99  I00  105  107 
R  S  Y  Y  G  G  S  Y  F  D  Y 
AGA  TCN  NNN  TAC  TAT  GGT  GGT  AGC  TAC  NNN  TTT  GAC  TAC 
.....  C  CAT  ..............  T  . .T TAC  ......... 
￿9 .C CAT  ..................  TAC  .. 
￿9 .C CAT  ..................  TAC  .. 
￿9 .C CAT  . .T  ........  A  ......  TAC  ......... 
￿9 C  CAT  ..................  TAC  ......... 
￿9 .C CAT  ..................  TAC  ......... 
......  GAT  ..................  TCC  ......... 
......  GAT  ......  A ..........  G  TCC  C ........ 
......  GAT  ..................  TCC  ......... 
......  GAT  ..................  TCC  ......... 
......  GAT  .............  C ....  TCC  ......... 
.....  T  CAT  ..................  TAC  ......... 
￿9  T  CAT  ..................  TAC  ......... 
....  T  CAT  . .T  ...............  TAC  ......... 
......  CAT  ..  T  ...........  T  ...  GAC  ......... 
CAT  ..................  GAC  ... 
.....  T  CAT  ..................  TGC  ......... 
.....  C  AAT  ..................  CAC  ......... 
.....  C  AAT  ..............  T  , ,T TGC  ......... 
......  A~-T  ..................  CTT  ......... 
AAT  ..................  CTT  ... 
......  AAT  ....  T .............  CTT  ... 
AAT  ....  T .............  CTT  ... 
......  CAT  ..................  TAC  ........ 
......  CAT  ..................  TAC  .., 
......  CAT  ..................  TAC 
......  CAT  ..................  TAC  ... 
......  CAT  ..................  TGC  ........ 
......  CAT  ..................  TGC  ... 
......  CAT  TC-C  ...... 
......  CAT  ..............  T  ...  TGC 
......  CAT  ..................  TCC  ......... 
CAT  TCC 
.....  C  TTC  , .T G.,  .T.  TAC  TCG  ,..  TAC  ......... 
.....  A  AAT  ..................  GTC  ......... 
.....  A  AAT  .............  T ....  GTC 
.....  A  AAT  .............  T ....  GTC  ......... 
.....  A  A~T  ..................  GTC  ......... 
.....  A  AAT  ....  T  .....  A.  .T ....  GTC 
C ....  A  AAT  .......  C ....  TA ....  ~TC  ......... 
.....  A  AAT  ......  A..  .C.  GTC 
.....  A  AAT  ..............  T  ...  GTC  ......... 
.....  A  AAT  ..................  GTC  ......... 
.....  A  AAT  ..............  T  ...  GTC  ......... 
.....  A  AAT  .............  T ....  GTC  ......... 
.....  AAAT  ....  T ........  C ....  GTC  ......... 
.....  A  AAT  .............  C ....  GTC  ......... 
￿9 G  GCC  - - -  ....  A.  TAC  GTG  TAC  ...... 
Figure  5.  Lineage assignments based on VH  CDR3 junctional se- 
quences. Nucleotide sequences obtained from E4  § cells of four mice are 
shown￿9 The variable junctional nucleotides are denoted "N" in the refer- 
ence sequence (5, 27). Dots indicate identity with the reference sequence￿9 
Mutations resulting in amino acid changes (replacement mutations) are in 
bold. Two ambiguous  bases are underlined￿9  Sample nomenclature is con- 
sistent with other figures and tables (e.g., I-4H: mouse no. I, sample no. 4, 
H chain). Cells from a given mouse were assigned to a common lineage 
when their junctional sequences were identical. Two cells utilized nonca- 
nonical D segments. 
the Ars-specific  memory compartment is derived from ca- 
nonical  precursors,  we  estimate  the  total  hapten-specific 
memory  compartment  at  day  13  to  be  composed  of no 
more than 28 clones. 
Discussion 
E4  + B Cells Belong to Memory Lineages￿9  Our  interpreta- 
tion that E4 + splenocytes belong to hneages destined for the 
memory  compartment  is  based  in  part  on  previous  sero- 
logic  and hybridoma  sampling  studies.  A  large  fraction  of 
Ars-specific hybridomas isolated during the secondary (mem- 
ory) immune response express mutated versions of a highly 
defined  canonical  set  of V  gene  segments.  In  this  study, 
more  than  90%  of primary-response  E4 +  cells  that  were 
subjected to sequencing analysis carried V  genes with all of 
the  canonical  structural  hallmarks  including:  (a)  a  specific 
set of 5 V  gene segments;  (b) codons for two specific junc- 
tional residues;  (c) a uniform Vrt CDR3  length;  and (d) ac- 
quisition  of point  mutations.  In  addition,  large  E4 +  cells 
had a high frequency  of specific  afffinity-improving  muta- 
tions.  The kinetics of emergence  of this population of cells 
carrying mutated antibody V  genes was also consistent with 
the  kinetics  of germinal  center  development  and with  re- 
suits  of other investigators  (18,  21),  who  have shown that 
somatic  hypermutation  appears  to  be  confined  to  PNAhi 
germinal center B  cells.  E4 + cells also displayed other phe- 
notypic  characteristics  of germinal  center  centrocytes,  in- 
cluding a low level of surface Ig (40, 43,  48), an absence of 
surface IgD  (43, 49,  50),  a high level of receptors for PNA 
(39-44),  and enrichment  among larger cells  (10 p~m in di- 
ameter).  We  have also recently  observed that E4 +  cells do 
not secrete  antibody, as determined  using an ELISPOT  as- 
say  (data  not  shown).  The  basis  of the  bimodal  staining 
with B220 is unknown. Presumably the stained cells do not 
include plasma cells which are PNA~o (18,  42),  centroblasts 
which are reported to be slg-  (50a), or plasmablasts ofperi- 
arteriolar lymphoid sheaths,  which  do not mutate  their V 
genes  (14).  But we cannot exclude the possibility that they 
are recent slg + emigrants from the GC that are in the pro- 
cess of differentiating into plasma cells. 
Estimating Frequencies of Memory Progenitors.  Our  estimates 
detailed  above  indicate  that  fewer  than  40,000  E4 §  cells 
and  50,000  total  hapten-specific  memory-lineage  cells  per 
spleen were present at the time of their peak frequencies in 
primary-immunized A/J mice. E4 + cells that have lost their 
ability to bind Ars, presumably because  of deleterious  mu- 
tations, account for half of the canonical cells observed and 
are  presumably  destined  for  exclusion  from  the  memory 
compartment. 
Our estimate is at least 10-fold lower than the number of 
splenic  B  cells  observed to participate  in the primary NP- 
specific  immune  response  as  described  by others  (18,  21). 
The  numerical discrepancy between  the two studies  could 
be  due  to  differences  in  antigens,  adjuvants  or  strains  of 
mice used in the two systems.  However,  the primary anti- 
NP  response  appears to be dominated by kl-expressing  B 
2060  Development of B Cell Memory cells,  whereas  the  secondary  immune  response  to  NP  is 
dominated by kappa-expressing B  cells (22).  Further, rela- 
tively few hneages of NP-specific B cells dominate the sec- 
ondary immune response in a given animal (23).  This indi- 
cates that the lambda-expressing clonotypes are superseded 
by minor kappa-bearing populations that are preferentially 
recruited and expanded into the memory pool.  Thus,  the 
early domination by h 1-bearing B cells could be due to an 
inordinately high frequency of precursor cells. 
We calculated that the E4 §  cells  isolated 13  d  after im- 
munization originated from only 1 to 11 clonal precursors, 
and thus the complete Ars-specific memory cell compart- 
ment was probably derived from 1 to 28 precursors. This 
indicates that clone sizes varied from ~4,000  to ~40,000 
cells at day 13. This precursor estimate is in agreement with 
the observation, based on hybridoma samphng studies, that 
late primary or secondary immune responses are generally 
dominated by relatively few clones of B  cells  (10-12,  23, 
24).  However,  it is  substantially lower than  the  300-500 
germinal  centers  estimated to  develop  in  response  to  the 
hapten  NP  (21).  Since  germinal  centers  are  the  sites  of 
memory B  cell development (16,  18-20,  43,  44,  54),  our 
estimate suggests one of two possibilities to reconcile these 
differences: only a small minority of germinal centers ulti- 
mately contribute  to  the  memory B  cell  repertoire,  or  a 
small number of clonal precursors populate numerous ger- 
minal centers in a given animal. 
E4 + Cells  Are Phenotypically Diverse and Represent an Inter- 
mediate Stage in Memory Development.  E4 +  B  cells  sampled 
13  d  after Ars  immunization  manifested  an  intermediate 
degree of hypermutation and clonal expansion when com- 
pared with their secondary response counterparts. Anti-Ars 
memory B cells typically reveal a frequency ofV gene mu- 
tations in the range of 2-8% when sampled after secondary 
exposure to antigen (reviewed in 13,  51). Furthermore, si- 
lent or noncoding mutations are often shared by memory 
B  cells  in a way that reveals the genealogy of their clonal 
development (10, 11).  In contrast, the frequency of somatic 
mutations  in  our  E4-specific  cells  was  only  ~0.5-1.0%. 
While  some replacement mutations and,  in particular,  af- 
finity-improving mutations, were shared, there was no shar- 
ing  of silent  mutations  among  clonally  related  members. 
Thus, the E4 + cells had apparently sustained an intermedi- 
ate degree of somatic mutagenesis and selection by 13 d af- 
ter immunization. 
Evidence  for  ongoing  selection  was  also  supported by 
heterogeneity within  the  E4 +  population.  We found that 
the presence of ArsBSA in the staining buffer reduced the 
frequency of cells that stained with E4 by "~  This sug- 
gests that many of the canonical cells had acquired V  gene 
mutations that diminished or abolished the capacity of their 
antibody products to bind Ars,  and that antigen-based se- 
lection was in progress at the time of cell sampling. We in- 
fer that these presumed deleterious somatic mutations were 
recently acquired because antigen binding loss variants are 
short-lived without  the benefit of antigen-based selection 
(8, 52, 53, 55). 
Evidence for heterogeneity could also be seen between 
large and small E4 +  cells.  Clonally related E4 +  cells  from 
one mouse were found among both large and small cells. 
Interestingly, the small cells had VH CDR2 and CDR3 that 
were more heavily mutated than those of the large cells, yet 
they were nearly devoid of the specific mutations associated 
with affinity improvements (for binding to Ars)  and posi- 
tive  selection.  Perhaps  the  small  E4  +  cells,  without  the 
benefit of affinity-improving mutations,  were undergoing 
apoptosis, an early sign of which is a contraction in cell vol- 
ume (56). 
It is possible that some of the E4 +  cells  were mutating 
their antibody V  genes  at the  time of isolation.  Of those 
that produced amplified canonical gene products  (derived 
from chromosomal DNA), ~50% yielded only a heavy or a 
hght chain product.  In contrast, the concordance between 
amphfied heavy and light chain gene products was "~90% 
for hybridoma cells  (38).  One possible explanation for this 
difference is that some of the E4 + cells may have sustained 
cuts within their V gene templates, perhaps due to the pro- 
cess  of  somatic  mutagenesis.  Any  interruption  between 
primer sites would preclude successful amplification. Jacob 
et al. (16)  observed a high frequency of PCR hybrid prod- 
ucts derived from groups of sampled germinal center cells 
and also suggested that this might be an indication of DNA 
modification. DNA nicking has been proposed to be nec- 
essary in several models ofV gene hypermutation, although 
no direct evidence for this has been reported to date (51). 
Finally, the 255 observed mutations included six ambig- 
uous  bases  where  signals  were  seen  in  two  lanes  of se- 
quencing ladders. Five of the six mutations were transition 
substitution mutations, which is consistent with the pattern 
of somatic hypermutation. While this frequency is close to 
the expected frequency of Taq polymerase errors (~4  Taq 
errors/30917  sequenced bases), four of the five ambiguous 
transition mutations were G  to A  (three) or C  to T  (one), 
while Taq Polymerase misincorporations tend to be A to G 
or T  to  C  transitions  (57-59).  Thus,  the  observed single 
base differences between  complementary DNA strands  of 
the same V  gene product could be the result of newly ac- 
quired point mutations. 
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